Life Sciences

Market Access

New NICE Advice service

Leela Barham digs into what’s publicly available on the success of NICE Advice just as the institute launched a refreshed offer to life sciences companies.

Market Access

Life sciences inspections and investigations

In a firmly post-pandemic world, regulators such as the Medicines and Healthcare products Regulatory Agency (MHRA) have increased the frequency and depth of in-person inspections of pharmac

News

Gilde’s new investment fund reaches €740m at close

Netherlands-based investment group Gilde Healthcare has finally closed its new Venture & Growth VI fund with committed funding of €740 million, well ahead of its origi

Oncology

Resilience, empathy, and gratitude. A personal battle with b...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Nataliya Andreychuk, CEO of Viseven, about her personal battle with breast cancer.

Sales & Marketing

Focussing on finding value in health sciences marketing

In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with life sciences advisor Randall Hein, CEO of Heinsight LLC, and health sciences marketing expert K

Sales & Marketing

Scientists in the C-suite: Attracting investors takes more t...

In the ever-evolving landscape of the biotechnology sector, the ability to attract investors effectively stands as the decisive factor that separates the success of your pioneering research